The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
about
In 2014, can we do better than CA125 in the early detection of ovarian cancer?The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomasTowards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studiesPlasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.Comparison of HE4, CA125, and ROMA Diagnostic Accuracy: A Prospective and Multicenter Study for Chinese Women With Epithelial Ovarian Cancer.Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings.Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese womenM-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patientsDiscrepant clinicopathologic characteristics and HE4 performance in type I and type II epithelial ovarian cancer.Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.Ovarian cancer: in search of better marker systems based on DNA repair defectsBiomarker testing for ovarian cancer: clinical utility of multiplex assaysThe plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors.Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses.The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer.The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.Comparison of the Serum Level of Cancer Antigen 125 and Human Epididymis Protein 4 in Ovarian Cancer Patients and Healthy Groups in Isfahan City.Is serum human epididymis protein 4 ready for prime time?Assessment of Diagnostic Values among CA-125, RMI, HE4, and ROMA for Cancer Prediction in Women with Nonfunctional Ovarian Cysts
P2860
Q26825152-FA2310A9-7E30-4876-BB4A-718363441B22Q26992102-42BDC1E7-9C43-4585-881D-ED870E2BCD7AQ30414041-230C6C21-B8CA-401D-A14D-16382353DD1EQ32173966-4B67FA3E-CC81-4225-849B-ACB57436F045Q34391119-C5AD96AC-61E1-4DB9-8DB1-B04199DDBBF5Q34675023-FABBDAD4-AA78-4C0C-B33F-89A26CC1B1F1Q34996986-16AD4095-0463-4240-91F2-2BC26B07DACCQ35126762-0DF90543-E086-4C87-B8C9-A10FD658B7B4Q35589339-0856307D-56C9-45FB-8EB0-0B982D575EA8Q35925743-CAB3FF93-6A14-451F-AD1C-5CDA306DAC49Q36400522-D6B6A0E9-8DEB-484F-AEFB-FDCFC554DCBEQ36589947-905432F7-2CE9-4F38-AB5C-872FC80F14A8Q36897149-34A78704-E333-417A-9248-D17CEA318301Q36996525-9674B86B-5206-4507-A88E-13E5714366FBQ37111350-E7E527D7-0405-4C63-B73B-4A7FBAA494F8Q38388103-83B624E9-4106-4C5D-B52A-709E817450DEQ38653169-AB0A6BA5-D84B-465A-9FE7-40DE7610852AQ47124965-12A002FA-35ED-46EB-A783-7A50AFCFC233Q50773867-BD74F041-5440-4223-8D63-D410A2377F82Q58580738-7113D713-0EB1-4E9D-BEF4-82AFDAB2CF55
P2860
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
@en
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
@nl
type
label
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
@en
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
@nl
prefLabel
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
@en
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
@nl
P2093
P1433
P1476
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
@en
P2093
Aw-Tar Choon
Beth A Schodin
Jaganathan Sickan
Joo-Hyun Nam
Kazunori Ochiai
Sarikapan Wilailak
Subathra Sabaratnam
Sudarshan Hebbar
Walfrido W Sumpaico
P304
P356
10.1016/J.YGYNO.2012.09.034
P407
P577
2012-10-10T00:00:00Z